- Home
- HUMA vs SENS Comparison
HUMA vs SENS Comparison
Compare HUMA & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- SENS
- Stock Information
- Founded
- HUMA 2004
- SENS 1996
- Country
- HUMA United States
- SENS United States
- Employees
- HUMA N/A
- SENS N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- SENS Industrial Machinery/Components
- Sector
- HUMA Health Care
- SENS Industrials
- Exchange
- HUMA Nasdaq
- SENS Nasdaq
- Market Cap
- HUMA 324.0M
- SENS 360.5M
- IPO Year
- HUMA N/A
- SENS N/A
- Fundamental
- Price
- HUMA $1.71
- SENS $7.12
- Analyst Decision
- HUMA Strong Buy
- SENS Strong Buy
- Analyst Count
- HUMA 7
- SENS 6
- Target Price
- HUMA $10.00
- SENS $28.67
- AVG Volume (30 Days)
- HUMA 7.6M
- SENS 707.8K
- Earning Date
- HUMA 11-07-2025
- SENS 11-05-2025
- Dividend Yield
- HUMA N/A
- SENS N/A
- EPS Growth
- HUMA N/A
- SENS N/A
- EPS
- HUMA N/A
- SENS N/A
- Revenue
- HUMA $818,000.00
- SENS $25,466,000.00
- Revenue This Year
- HUMA N/A
- SENS $62.96
- Revenue Next Year
- HUMA $1,686.52
- SENS $72.62
- P/E Ratio
- HUMA N/A
- SENS N/A
- Revenue Growth
- HUMA N/A
- SENS 5.94
- 52 Week Low
- HUMA $1.15
- SENS $5.00
- 52 Week High
- HUMA $6.77
- SENS $28.00
- Technical
- Relative Strength Index (RSI)
- HUMA 48.43
- SENS 76.72
- Support Level
- HUMA $1.65
- SENS $6.98
- Resistance Level
- HUMA $1.90
- SENS $7.56
- Average True Range (ATR)
- HUMA 0.10
- SENS 0.44
- MACD
- HUMA -0.01
- SENS 0.50
- Stochastic Oscillator
- HUMA 42.03
- SENS 80.30
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.